Akoya BioSciences
AKYA
AKYA was delisted on the 7th of July, 2025.
59 hedge funds and large institutions have $32.9M invested in Akoya BioSciences in 2024 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 17 reducing their positions, and 7 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
24% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 17
13% more capital invested
Capital invested by funds: $29M → $32.9M (+$3.91M)
0% more funds holding
Funds holding: 59 → 59 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
0.65% less ownership
Funds ownership: 25.08% → 24.43% (-0.65%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture
Dallas,
Texas
|
+$1.07M |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$354K |
| 3 |
BlackRock
New York
|
+$191K |
| 4 |
Morgan Stanley
New York
|
+$152K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$108K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SW
SVB Wealth
Boston,
Massachusetts
|
-$1.21M |
| 2 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$772K |
| 3 |
Charles Schwab
San Francisco,
California
|
-$276K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$181K |
| 5 |
Squarepoint
New York
|
-$154K |
AKYA Hedge Fund Activity: Q3 2024 in Review
59 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Akoya BioSciences (AKYA) for Q3 2024, worth a combined $32.9M — up 13% from $29M a quarter earlier.
Fund positioning in AKYA was balanced in Q3 2024: 7 funds opened new positions, 7 closed out, 21 added to existing stakes and 17 trimmed.
The largest buyer was Paragon Associates & Paragon Associates II Joint Venture, adding an estimated $1.07M. The largest seller was SVB Wealth, exiting entirely with an estimated $1.21M sold.
- 59 institutional investors held Akoya BioSciences (AKYA) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $32.9M of Akoya BioSciences stock for Q3 2024, up 13% quarter-over-quarter.
- 7 funds opened new Akoya BioSciences positions in Q3 2024 and 7 closed out, a net change of 0 holders.
- The largest Akoya BioSciences buyer in Q3 2024 was Paragon Associates & Paragon Associates II Joint Venture, an estimated $1.07M added.
- The largest Akoya BioSciences seller in Q3 2024 was SVB Wealth, an estimated $1.21M sold.
Based on aggregated 13F filings for Q3 2024.